ERK MAP kinase signaling in post-mortem brain of suicide subjects: differential regulation of upstream Raf kinases

Y Dwivedi1, H S Rizavi, R R Conley

  • 1Department of Psychiatry, University of Illinois at Chicago, 1601 West Taylor Street, Chicago, IL 60612, USA. ydwivedi@psych.uic.edu

Molecular Psychiatry
|September 21, 2005
PubMed

Insights

Investigating suicide brain tissue, this study found reduced B-Raf kinase activity and protein levels, suggesting its role in altered extracellular signal-regulated kinase (ERK) signaling and suicide pathophysiology.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Psychiatry

Background:

  • Extracellular signal-regulated kinase (ERK) signaling is vital for brain functions like neuronal survival.
  • Previous studies indicated reduced ERK-1/2 activation in suicide brains.
  • Upstream activators of ERK signaling, Raf kinases (Raf-1 and B-Raf), were investigated.

Purpose of the Study:

  • To examine abnormalities in upstream ERK signaling molecules (Raf-1 and B-Raf) in the prefrontal cortex (PFC) and hippocampus of suicide victims.
  • To determine if B-Raf and Raf-1 protein levels, mRNA levels, and catalytic activities are altered in suicide brains.

Main Methods:

  • Quantitative RT-PCR to measure mRNA levels of Raf-1, B-Raf, and cyclophilin.
  • Western blot to determine protein levels of Raf-1 and B-Raf.
  • Immunoprecipitation and enzymatic assays to assess the catalytic activities of Raf-1 and B-Raf.

Main Results:

  • B-Raf catalytic activity was significantly reduced in the PFC and hippocampus of suicide subjects.
  • This reduction in B-Raf activity correlated with decreased protein levels, but not mRNA levels.
  • Raf-1 catalytic activity, mRNA, and protein levels remained unchanged in suicide brains.
  • B-Raf alterations were consistent across all suicide subjects, independent of psychiatric diagnosis.

Conclusions:

  • Selective reduction in B-Raf catalytic activity and expression, but not Raf-1, suggests B-Raf's significant role in altered ERK signaling in suicide brains.
  • These findings implicate B-Raf in the pathophysiology of suicide.
  • B-Raf may represent a potential therapeutic target for suicide prevention or treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...